Company Overview and News

0
Prakash Industries Limited - Updates

2018-08-18 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
506022 PRAKASH

0
Prakash Industries Limited - Appointment

2018-08-13 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
506022 PRAKASH

0
Prakash Industries Limited - Shareholders meeting

2018-07-30 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
506022 PRAKASH

0
Prakash Industries Limited - Updates

2018-07-20 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
506022 PRAKASH

0
Prakash Industries Limited - News Verification

2018-07-19 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
506022 PRAKASH

0
Prakash Industries Limited - News Verification

2018-07-19 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
506022 PRAKASH

0
Prakash Industries Limited - Statement of deviation(s) or variation(s) under Reg. 32

2018-07-11 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
506022 PRAKASH

0
IndusInd Bank: Eyes on Q1 provisioning

2018-07-09 thehindubusinessline
Apart from TCS, a leading private sector lender IndusInd Bank, and Prakash Industries will declare their first quarter results for the period ended June, on Tuesday. Though analysts expect IndusInd Bank to report consistent performance, some fear high provisioning for bad loans and MTM on its investment portfolios may drag the bank’s performance. The stock may come under pressure, if the performance fails to meet street expectations.
506022 500470 TTST 532187 TATASTEEL TATLY INDUSINDBK PRAKASH

0
Market Live: Nifty at day#39;s high, Sensex up over 250 pts; Bajaj Auto, Bharti Infratel top gainers

2018-07-04 moneycontrol
Buzzing: Unichem Laboratories share price rallied more than 5 percent intraday after the company received final ANDA approval for its Montelukast Chewable tablets, 4 mg and 5 mg from the United States Food and Drug Administration to market in the US.
BAJAJ-AUTO KOHINOOR BHRYY 500325 UBL RELIANCE 532978 532977 SRTRANSFIN 532478 511218 532783 532121 506690 534816 RIGD SRRQY BJJQY INFRATEL RLNIY 500034 UNICHEMLAB UBHOLDINGS UNBWY 512559 506022 BAJAJFINSV BAJFINANCE PRAKASH DENABANK 507458 DAAWAT

4
Market Live: Sensex up 150 pts despite global weakness; HDFC twins, RIL lead

2018-07-04 moneycontrol
Europe Update: European stocks were slightly lower Wednesday morning, amid elevated tensions between the US and China over looming trade tariffs and investment restrictions.
BAJAJ-AUTO KOHINOOR 500325 533271 UBL RELIANCE ASHOKA 532978 532977 532712 SRTRANSFIN 532478 511218 532783 500470 532121 RCOM RIGD SRRQY BJJQY 500570 TATAMOTORS 509488 RLNIY 500034 GRAPHITE UBHOLDINGS 532967 UNBWY KIRIINDUS BHEL 512559 506022 BAJAJFINSV BAJFINANCE TTST TATASTEEL TATLY PRAKASH BRHTY 500103 DENABANK 507458 DAAWAT TTM

0
Prakash Industries stock gains 3% on highest ever quarterly sales volume in Q1

2018-07-04 moneycontrol
Prakash Industries share price gained nearly 3 percent intraday on Wednesday on reporting highest ever quarterly sales volume in Q1FY2019.
506022 PRAKASH

4
Market Live: Rangebound trade continues at Dalal Street; Shriram Transport tumbles

2018-07-04 moneycontrol
Ducon Infratechnologies at upper circuit; Shares of Ducon Infratechnologies were locked at 20 percent upper circuit at Rs 22.80 following new orders for its US subsidiary.
BAJAJ-AUTO 500325 533271 UBL RELIANCE ASHOKA 532978 532977 532712 SRTRANSFIN 532478 511218 500470 532121 RCOM RIGD SRRQY BJJQY 500570 TATAMOTORS 509488 RLNIY 500034 GRAPHITE UBHOLDINGS 532967 UNBWY KIRIINDUS BHEL 506022 BAJAJFINSV BAJFINANCE TTST TATASTEEL TATLY PRAKASH BRHTY 500103 DENABANK 507458 TTM

0
Prakash Industries Limited - Press Release

2018-07-04 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
506022 PRAKASH

29
Market Live: Sensex falls 300 pts, metals lose shine; Europe falls 1% amid trade tensions

2018-07-02 moneycontrol
Europe Update: Shares in Europe opened sharply lower as investors question the stability of the German government and wider trade links between the European Union and the US.
BAJAJ-AUTO BHRYY 500325 524816 RELIANCE IDBI TCHQY ICLQY 532977 BHRQY 532755 500470 NATCOPHARM 534816 RIGD 500477 INFRATEL 500570 BHARTIARTL TATAMOTORS RLNIY ASHOKLEY 500116 VOD VOD TATAPOWER 532822 AKLD TECHM 532454 506022 TTST VODPF TATASTEEL TATLY PRAKASH IDEA 500102 TPCL 500400 BALLARPUR AKLS TTM

Related Articles

REPH: Recro Pharma Analysis and Research Report

2018-08-20 - Asif

Overview Recro Pharma is a specialty pharmaceutical company that operates through two business divisions: an Acute Care division and a revenue-generating CDMO division. Each of these divisions are deemed to be reportable segments for financial reporting purposes. The company's Acute Care segment is primarily focused on developing and commercializing innovative products for hospital and related acute care settings. The company's lead product candidate is a proprietary injectable form of meloxicam, a long-acting preferential COX-2 inhibitor. IV meloxicam has successfully completed three Phase III clinical trials for the management of moderate to severe pain, consisting of two pivotal efficacy trials and a large double-blind Phase III safety trial, as well as other safety studies. Overall, the total new drug application, or NDA, program included over 1,400 patients. In late July 2017, the company submitted a NDA to the U.S. Food and Drug Administration, or FDA, for IV meloxicam...

ACHN: Achillion Pharmaceuticals Analysis and Research Report

2018-08-20 - Asif

Overview Achillion Pharmaceuticals is a clinical-stage biopharmaceutical company focused on advancing its oral factor D inhibitors into late-stage development and commercialization. Each of the drug candidates in its oral factor D portfolio was discovered in its laboratories and is wholly owned by it. Achillion Pharmaceuticals is focusing its drug development activities on alternative pathway-mediated, rare diseases where there are no approved therapies or where existing therapies are inadequate for patients. To advance its investigational drugs into phase III and commercialization, the company plan to work closely with key stakeholders including patients, payors, regulators and healthcare professionals. The company's first-generation factor D inhibitor, ACH-4471, has demonstrated preliminary clinical proof-of-concept in patients with C3 glomerulopathy, or C3G, a disease affecting the kidney, and paroxysmal nocturnal hemoglobinuria, or PNH, a blood disorder, and has advanced...

BTE: Baytex Energy Trust Analysis and Research Report

2018-08-20 - Asif

General Baytex Energy Corp. was incorporated on October 22, 2010 pursuant to the provisions of the ABCA. Baytex is the successor to the business of Baytex Energy Trust, which was transitioned to Baytex on December 31, 2010. Inter-Corporate Relationships The following table provides the name, the percentage of voting securities owned by it and the jurisdiction of incorporation, continuance, formation or organization of its material subsidiaries either, direct and indirect, as at the date hereof. ||Percentage of voting securities (directly or indirectly)|Jurisdiction of Incorporation/Formation| | ------------ | ------------: | :------------: | |Baytex Energy Ltd.|100%|Alberta| |Baytex Energy USA, Inc.|100%|Delaware| |Baytex Energy Partnership|100%|Alberta| Organizational Structure The following simplified diagram shows the inter-corporate relationships among it and its material subsidiaries as of the date hereof. <img src="https://www.sec.gov/A...